Forest bathing tested as fatigue fix for cancer survivors
NCT ID NCT06931132
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether nature-based therapies can reduce fatigue and improve sleep, mood, and concentration in cancer survivors. 172 participants will be assigned to real forest bathing, a virtual reality forest experience, guided imagery, or a waitlist. Each session lasts 30 minutes, once a week for 8 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- forest bathing (real, virtual reality, or guided imagery)
- What this could lead to
- If it works, this could offer a simple, drug-free way to help cancer survivors feel less tired and improve their quality of life.
- What could go wrong
- This is a small, early-stage trial with no blinding, so results may be influenced by expectations. The effects may be modest and not apply to all survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 172 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who have completed treatment for cancer (\*with the exception of long-term adjuvant endocrine therapy). * Subjective Impairment due to Cancer-Related Fatigue (CrF) . NCCN-recommended questions are used for screening ("How exhausted do you feel on a scale of 0 to 10?" and "How impaired do you feel by this fatigue on a scale of 0 to 10?" (threshold \>4 on either scale). * At the time of study inclusion, it must be expected that no further antitumor therapy measures will be started within the next 6 months. * Patients must be able to refrain from smoking up to 15 minutes before the intervention (smoking within 15 minutes before therapy impairs the participant's ability to perceive the aroma of the phytoncides). * Written and valid informed consent from the patient. Exclusion Criteria: * Presence of inadequately controlled major depression in the opinion of the investigator. * Asthma (inhaled phytoncides may cause airway irritation, exacerbation of asthma, or bronchoconstriction). * Known allergy to pine or citrus fragrance. * Anosmie. * Medical history of seasickness (virtual reality can cause nausea/vomiting with no improvement after 5-10 minutes). * History of seizures (virtual reality may increase susceptibility to seizures due to the changing light in the forest video). * Visual and hearing impairments that are not corrected by visual or hearing aids. * Unwillingness to store and share personal medical data as part of the protocol. * Participation in another clinical trial focusing on behavioural or complementary medicine interventions. * Missing or incomplete consent form.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dr med. Marcela Winkler
Stuttgart, Baden-Wurttemberg, 70439, Germany
-
PD Dr. Claudia Löffler
Würzburg, Bavaria, 97080, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?